The type IV phosphodiesterase specific inhibitor mesopram inhibits experimental autoimmune encephalomyelitis in rodents (Q74016831)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10900347%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

title

The type IV phosphodiesterase specific inhibitor mesopram inhibits experimental autoimmune encephalomyelitis in rodents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10900347%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

author name string

H Dinter

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10900347%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

J Tse

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10900347%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

M Halks-Miller

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10900347%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

D Asarnow

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10900347%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

J Onuffer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10900347%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

D Faulds

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10900347%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

B Mitrovic

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10900347%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

G Kirsch

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10900347%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

H Laurent

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10900347%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

P Esperling

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10900347%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

D Seidelmann

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10900347%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

E Ottow

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10900347%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

H Schneider

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10900347%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

V K Tuohy

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10900347%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

H Wachtel

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10900347%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

H D Perez

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10900347%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

publication date

1 August 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10900347%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuroimmunology

8 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10900347%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

108

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10900347%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10900347%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

136-146

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10900347%20AND%20SRC:MED&resulttype=core&format=json

Functional diversity of helper T lymphocytes

8 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900265-4

7 January 2021

Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900265-4

7 January 2021

Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900265-4

7 January 2021

Lymphocyte suppression by rolipram with other immunosuppressive drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900265-4

7 January 2021

Elevation of intracellular cyclic AMP induces an anergic-like state in Th1 clones

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900265-4

7 January 2021

Expression and regulation of human and rat phosphodiesterase type IV isogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900265-4

7 January 2021

Treatment with BBB022A or rolipram stabilizes the blood-brain barrier in experimental autoimmune encephalomyelitis: an additional mechanism for the therapeutic effect of type IV phosphodiesterase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900265-4

7 January 2021

Ibudilast, a phosphodiesterase inhibitor, ameliorates experimental autoimmune encephalomyelitis in Dark August rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900265-4

7 January 2021

Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900265-4

7 January 2021

The specific type IV phosphodiesterase inhibitor rolipram differentially regulates the proinflammatory mediators TNF-alpha and nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900265-4

7 January 2021

Repression of class II major histocompatibility complex genes by cyclic AMP is mediated by conserved promoter elements

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900265-4

7 January 2021

Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900265-4

7 January 2021

Preventive but not therapeutic application of Rolipram ameliorates experimental autoimmune encephalomyelitis in Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900265-4

7 January 2021

Both a monoclonal antibody and antisera specific for determinants unique to individual cloned helper T cell lines can substitute for antigen and antigen-presenting cells in the activation of T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900265-4

7 January 2021

cAMP up-regulates IL-4 and IL-5 production from activated CD4+ T cells while decreasing IL-2 release and NF-AT induction

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900265-4

7 January 2021

Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900265-4

7 January 2021

Immunological aspects of demyelinating diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900265-4

7 January 2021

Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900265-4

7 January 2021

Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900265-4

7 January 2021

cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900265-4

7 January 2021

Critical Influences of the Cytokine Orchestration on the Outcome of Myelin Antigen‐Specific T‐Cell Autoimmunity in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900265-4

7 January 2021

Patterns of oligodendroglia pathology in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900265-4

7 January 2021

Differential effects of phosphodiesterase type 4-specific inhibition on human autoreactive myelin-specific T cell clones

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900265-4

7 January 2021

A new view of prostaglandin E regulation of the immune response.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900265-4

7 January 2021

Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1- but not type 2-associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900265-4

7 January 2021

Effect of phosphodiesterase inhibition on IL-4 and IL-5 production of the murine TH2-type T cell clone D10.G4.1.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900265-4

7 January 2021

Therapeutic potential of phosphodiesterase type 4 inhibition in chronic autoimmune demyelinating disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900265-4

7 January 2021

The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900265-4

7 January 2021

Role of membrane immunoglobulin (Ig) crosslinking in membrane Ig-mediated, major histocompatibility-restricted T cell-B cell cooperation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900265-4

7 January 2021

Interferon-gamma and Ia antigen are present on astrocytes in active chronic multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900265-4

7 January 2021

Encephalitogenic Th1 cells are inhibited by Th2 cells with related peptide specificity: relative roles of interleukin (IL)-4 and IL-10.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900265-4

7 January 2021

Multiple Sclerosis: Distribution of T Cell Subsets Within Active Chronic Lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900265-4

7 January 2021

Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by non-radioactive in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900265-4

7 January 2021

Results of a phase II study of the antidepressant effect of rolipram

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900265-4

7 January 2021

10.1016/S0165-5728(00)00265-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10900347%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference